Yahoo Web Search

Search results

1. Bristol-Myers Squibb Company

   NYSE: BMY

   49.80

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.16 (-0.32%)

   At close:4:00 PM EDTThu. Sep 5, 2024

   49.80 0.00 (0.00%)

   After hrs:7:55 PM EDTThu. Sep 5, 2024

   Delayed Quote (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	50.08
     High	50.24
     Low	49.23

   • Mkt Cap	100.96B
     P/E (TTM)	N/A
     Div & Yield	2.40 & 4.80%

   • Prev. Close	49.96
     52 Wk. Low	39.35
     52 Wk. High	61.43

   More about BMY

   What analysts are saying

   Argus Published July 31 · Bristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, immunology and cardiovascular conditions.... Read more

   Top stories

   • BMY
     -0.32%
   • CELG-RT

   Is Bristol-Myers Squibb Company (BMY) The Best Beaten Down Dividend Stocks to Invest in Now?

   Yahoo Finance · 5 hours ago

   

   • BMY
     -0.32%

   ArsenalBio secures $325m to develop cell therapy programmes

   Yahoo Finance · 18 hours ago

   

   • BMY
     -0.32%

   Bristol Myers Squibb’s CAMZYOS offers benefits in oHCM trial

   Yahoo Finance · 4 days ago

   

   Related stocks

   • MRK
     Merck & Co., Inc.
     MRK
     118.59
     +2.41%
   • LLY
     Eli Lilly and Company
     LLY
     912.75
     -3.55%
   • ABT
     Abbott Laboratories
     ABT
     113.10
     -1.14%
   • ABBV
     AbbVie Inc.
     ABBV
     192.86
     -2.11%
   • AMGN
     Amgen Inc.
     AMGN
     324.36
     -1.90%

   More on Yahoo Finance

2. stockanalysis.com › stocks › bmyBristol-Myers Squibb Company (BMY) - Stock Analysis

   stockanalysis.com › stocks › bmy

   • Cached

   Get a real-time Bristol-Myers Squibb Company (BMY) stock price quote with breaking news, financials, statistics, charts and more.

   • Market Cap: 100.07B
   • Revenue (ttm): 46.51B

   • Net Income (ttm): 6.54B
   • Shares Out: 2.03B

3. www.morningstar.com › stocks › xnysBMY Stock Price Quote | Morningstar

   www.morningstar.com › stocks › xnys

   • Cached

   Aug 30, 2024 · See the latest Bristol-Myers Squibb Co stock price (BMY:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

   • Current Ratio: 1.16
   • Quick Ratio: 0.94

   • Interest Coverage: −3.16

4. stockanalysis.com › stocks › bmyBristol-Myers Squibb Company (BMY) Stock Forecast & Price ...

   stockanalysis.com › stocks › bmy

   • Cached

   2 days ago · The 16 analysts with 12-month price forecasts for BMY stock have an average target of 56.5, with a low estimate of 42 and a high estimate of 84. The average target predicts an increase of 12.94% from the current stock price of 50.03.

5. People also ask

   Should you buy BMY (BMY) stock?

   • The average target predicts an increase of 12.94% from the current stock price of 50.03. The average analyst rating for BMY stock from 17 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

   Bristol-Myers Squibb Company (BMY) Stock Forecast & Price Targets

   stockanalysis.com/stocks/bmy/forecast/

   See all results for this question

   Why did Bristol-Myers Squibb (BMY) stock rise Friday?

   • U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Friday. Bristol-Myers Squibb (BMY) shares climbed Friday after the company beat expectations with its second-quarter results and raised its full-year guidance. Bristol Myers Stock Jumps. A Sales Jump for Eliquis Boosts Earnings.

   Bristol-Myers Squibb Company (BMY) - Stock Analysis

   stockanalysis.com/stocks/bmy/

   See all results for this question

   Should you buy Bristol-Myers Squibb (BMS) stock?

   • Despite recent downgrades by some analysts, Bristol-Myers Squibb's stock price has shown resilience and stability, making it an attractive investment option. Continuous research and development efforts by the company indicate a commitment to innovation and staying competitive in the biopharmaceutical industry.

   Bristol-Myers Squibb (BMY) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NYSE/BMY/

   See all results for this question

   Will Bristol Myers Squibb (BMY) stock trade higher in Q2 2024?

   • PRINCETON, N.J.-- (BUSINESS WIRE)--Bristol Myers Squibb Reports Second Quarter Financial Results for 2024. Bristol Myers Squibb (NYSE: BMY) is scheduled to report its Q2 2024 results on Friday, July 26. We expect BMY stock to trade higher, with its revenue and earnings likely exceeding the street estimates...

   Bristol-Myers Squibb Company (BMY) - Stock Analysis

   stockanalysis.com/stocks/bmy/

   See all results for this question

6. www.marketbeat.com › stocks › NYSEBristol-Myers Squibb (BMY) Stock Price, News & Analysis

   www.marketbeat.com › stocks › NYSE

   • Cached

   2 days ago · Should You Buy or Sell Bristol-Myers Squibb Stock? Get The Latest BMY Stock Analysis, Price Target, Dividend Info, Headlines, and Short Interest at MarketBeat.

   • 4.8/5
   • Employees: 34K

   • Email: john.elicker@bms.com

7. www.bloomberg.com › quote › BMY:USBMY: Bristol-Myers Squibb Co Stock Price Quote - New York ...

   www.bloomberg.com › quote › BMY:US

   • Cached

   2 days ago · Stock analysis for Bristol-Myers Squibb Co (BMY:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

   • Employees: 34K

8. www.cnbc.com › quotes › BMYBMY: Bristol-Myers Squibb Co - Stock Price, Quote and News - CNBC

   www.cnbc.com › quotes › BMY

   • Cached

   Aug 30, 2024 · 52 Week Low 39.35. 52 Week Low Date 07/05/24. Market Cap 101.268B. Shares Out 2.03B. 10 Day Average Volume 8.59M. Dividend 2.40. Dividend Yield 4.80%. Beta 0.46. YTD % Change -2.65.

9. stockanalysis.com › stocks › bmyBristol-Myers Squibb Company (BMY) Company ... - Stock Analysis

   stockanalysis.com › stocks › bmy

   • Cached

   6 days ago · Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases.